Last $34.83 USD
Change Today -0.48 / -1.36%
Volume 991.8K
SGEN On Other Exchanges
As of 8:10 PM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David W. Gryska

Director, Chairman of Audit Committee and Member of Compensation Committee, Seattle Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 33 board members in 6 different organizations across 11 different industries.

See Board Relationships


Mr. David W. Gryska, also known as Dave, has been Strategic Advisor to the Board at Novogen Limited since March 3, 2014. Mr. Gryska served as an Interim Chief Executive Officer of Myrexis Inc., from August 15, 2012 to December 24, 2012. He served as Chief Operating Officer of Myrexis, Inc., from May 11, 2012 to December 24, 2012 and served as its President from August 2012 to December 24, 2012. He served as an Executive Vice President and Chief Accounting Officer of ...

Read Full Background

Corporate Headquarters*

21823 30th Drive SE
Bothell, Washington 98021

United States

Phone: 425-527-4000
Fax: 425-527-4001

Board Members Memberships*

Former Director
Former Director
Independent Director and Chairman of Audit Committee
Director, Chairman of Audit Committee and Member of Compensation Committee
Former Lead Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Audit Committee and Member of Compensation Committee
Former Interim Chief Executive Officer, President, Chief Operating Officer and Director
Lead Independent Director, Chairman of Compensation Committee and Member of Audit Committee
Director and Member of Nominating & Governance Committee


Loyola University of Chicago
Golden Gate University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $34.83 USD -0.48


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at